These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 29797503)

  • 1. The effect of small doses of fructose and allulose on postprandial glucose metabolism in type 2 diabetes: A double-blind, randomized, controlled, acute feeding, equivalence trial.
    Noronha JC; Braunstein CR; Glenn AJ; Khan TA; Viguiliouk E; Noseworthy R; Blanco Mejia S; Kendall CWC; Wolever TMS; Leiter LA; Sievenpiper JL
    Diabetes Obes Metab; 2018 Oct; 20(10):2361-2370. PubMed ID: 29797503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Double-Blind, Randomized Controlled, Acute Feeding Equivalence Trial of Small, Catalytic Doses of Fructose and Allulose on Postprandial Blood Glucose Metabolism in Healthy Participants: The Fructose and Allulose Catalytic Effects (FACE) Trial.
    Braunstein CR; Noronha JC; Glenn AJ; Viguiliouk E; Noseworthy R; Khan TA; Au-Yeung F; Blanco Mejia S; Wolever TMS; Josse RG; Kendall CWC; Sievenpiper JL
    Nutrients; 2018 Jun; 10(6):. PubMed ID: 29890724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of fructose and its epimers on postprandial carbohydrate metabolism: A systematic review and meta-analysis.
    Braunstein CR; Noronha JC; Khan TA; Mejia SB; Wolever TM; Josse RG; Kendall CW; Sievenpiper JL
    Clin Nutr; 2020 Nov; 39(11):3308-3318. PubMed ID: 32220498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Effect of Small Doses of Fructose and Its Epimers on Glycemic Control: A Systematic Review and Meta-Analysis of Controlled Feeding Trials.
    Noronha JC; Braunstein CR; Blanco Mejia S; Khan TA; Kendall CWC; Wolever TMS; Leiter LA; Sievenpiper JL
    Nutrients; 2018 Nov; 10(11):. PubMed ID: 30463314
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of D-Allulose with Sucrose Beverage on Glucose Tolerance and Insulin Levels among Thai Healthy Volunteers.
    Buranapin S; Kosachunhanan N; Waisayanand N; Yokoi H; Tokuda M
    J Nutr Sci Vitaminol (Tokyo); 2024; 70(3):203-209. PubMed ID: 38945885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fructose acute effects on glucose, insulin, and triglyceride after a solid meal compared with sucralose and sucrose in a randomized crossover study.
    Gallagher C; Keogh JB; Pedersen E; Clifton PM
    Am J Clin Nutr; 2016 Jun; 103(6):1453-7. PubMed ID: 27099245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of D-allulose on glucose tolerance and insulin response to a standard oral sucrose load: results of a prospective, randomized, crossover study.
    Franchi F; Yaranov DM; Rollini F; Rivas A; Rivas Rios J; Been L; Tani Y; Tokuda M; Iida T; Hayashi N; Angiolillo DJ; Mooradian AD
    BMJ Open Diabetes Res Care; 2021 Feb; 9(1):. PubMed ID: 33637605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Control of postprandial plasma glucose by an oral insulin product (HIM2) in patients with type 2 diabetes.
    Kipnes M; Dandona P; Tripathy D; Still JG; Kosutic G
    Diabetes Care; 2003 Feb; 26(2):421-6. PubMed ID: 12547873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antihyperglycemic effect of short-term arginyl-fructose supplementation in subjects with prediabetes and newly diagnosed type 2 diabetes: randomized, double-blinded, placebo-controlled trial.
    Park SE; Kim OH; Kwak JH; Lee KH; Kwon YI; Chung KH; Lee JH
    Trials; 2015 Nov; 16():521. PubMed ID: 26578409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ascorbic acid supplementation improves postprandial glycaemic control and blood pressure in individuals with type 2 diabetes: Findings of a randomized cross-over trial.
    Mason SA; Rasmussen B; van Loon LJC; Salmon J; Wadley GD
    Diabetes Obes Metab; 2019 Mar; 21(3):674-682. PubMed ID: 30394006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Preliminary Study for Evaluating the Dose-Dependent Effect of d-Allulose for Fat Mass Reduction in Adult Humans: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Han Y; Kwon EY; Yu MK; Lee SJ; Kim HJ; Kim SB; Kim YH; Choi MS
    Nutrients; 2018 Jan; 10(2):. PubMed ID: 29385054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. d-Allulose enhances postprandial fat oxidation in healthy humans.
    Kimura T; Kanasaki A; Hayashi N; Yamada T; Iida T; Nagata Y; Okuma K
    Nutrition; 2017; 43-44():16-20. PubMed ID: 28935140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Pilot Study on the Efficacy of a Diabetic Diet Containing the Rare Sugar D-Allulose in Patients with Type 2 Diabetes Mellitus: A Prospective, Randomized, Single-Blind, Crossover Study.
    Fukunaga K; Yoshimura T; Imachi H; Kobayashi T; Saheki T; Sato S; Saheki N; Jiang W; Murao K
    Nutrients; 2023 Jun; 15(12):. PubMed ID: 37375710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postprandial metabolic effects of fructose and glucose in type 1 diabetes patients: a pilot randomized crossover clinical trial.
    Souto DL; Lima ÉDS; Dantas JR; Zajdenverg L; Rodacki M; Rosado EL
    Arch Endocrinol Metab; 2019 Jul; 63(4):376-384. PubMed ID: 31365624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Sustained Treatment With Lixisenatide on Gastric Emptying and Postprandial Glucose Metabolism in Type 2 Diabetes: A Randomized Controlled Trial.
    Rayner CK; Watson LE; Phillips LK; Lange K; Bound MJ; Grivell J; Wu T; Jones KL; Horowitz M; Ferrannini E; Tricò D; Frascerra S; Mari A; Natali A
    Diabetes Care; 2020 Aug; 43(8):1813-1821. PubMed ID: 32471908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-term effects of allulose consumption on glucose homeostasis, metabolic parameters, incretin levels, and inflammatory markers in patients with type 2 diabetes: a double-blind, randomized, controlled crossover clinical trial.
    Preechasuk L; Luksameejaroenchai C; Tangjittipokin W; Kunavisarut T
    Eur J Nutr; 2023 Oct; 62(7):2939-2948. PubMed ID: 37432472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved postprandial glycemic control with Humalog Mix75/25 after a standard test meal in patients with type 2 diabetes mellitus.
    Malone JK; Woodworth JR; Arora V; Yang H; Campaigne BN; Hallé JP; Yale JF; Grossman LD
    Clin Ther; 2000 Feb; 22(2):222-30. PubMed ID: 10743981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The once-daily human glucagon-like peptide-1 (GLP-1) analog liraglutide improves postprandial glucose levels in type 2 diabetes patients.
    Flint A; Kapitza C; Hindsberger C; Zdravkovic M
    Adv Ther; 2011 Mar; 28(3):213-26. PubMed ID: 21340616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lowering of postprandial lipids in individuals with type 2 diabetes treated with alogliptin and/or pioglitazone: a randomised double-blind placebo-controlled study.
    Eliasson B; Möller-Goede D; Eeg-Olofsson K; Wilson C; Cederholm J; Fleck P; Diamant M; Taskinen MR; Smith U
    Diabetologia; 2012 Apr; 55(4):915-25. PubMed ID: 22237690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pilot study on the effect of D-allulose on postprandial glucose levels in patients with type 2 diabetes mellitus during Ramadan fasting.
    Japar S; Fukunaga K; Kobayashi T; Imachi H; Sato S; Saheki T; Ibata T; Yoshimura T; Soh KL; Ong SL; Muhamed Z; Murao K
    Diabetol Metab Syndr; 2022 Jun; 14(1):86. PubMed ID: 35729673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.